1. Home
  2. OCGN vs COOK Comparison

OCGN vs COOK Comparison

Compare OCGN & COOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • COOK
  • Stock Information
  • Founded
  • OCGN 2013
  • COOK 1985
  • Country
  • OCGN United States
  • COOK United States
  • Employees
  • OCGN N/A
  • COOK N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • COOK Wholesale Distributors
  • Sector
  • OCGN Health Care
  • COOK Consumer Discretionary
  • Exchange
  • OCGN Nasdaq
  • COOK Nasdaq
  • Market Cap
  • OCGN 283.3M
  • COOK 255.1M
  • IPO Year
  • OCGN N/A
  • COOK 2021
  • Fundamental
  • Price
  • OCGN $1.09
  • COOK $1.83
  • Analyst Decision
  • OCGN Strong Buy
  • COOK Buy
  • Analyst Count
  • OCGN 3
  • COOK 7
  • Target Price
  • OCGN $6.00
  • COOK $2.43
  • AVG Volume (30 Days)
  • OCGN 6.6M
  • COOK 271.1K
  • Earning Date
  • OCGN 08-01-2025
  • COOK 08-05-2025
  • Dividend Yield
  • OCGN N/A
  • COOK N/A
  • EPS Growth
  • OCGN N/A
  • COOK N/A
  • EPS
  • OCGN N/A
  • COOK N/A
  • Revenue
  • OCGN $4,522,000.00
  • COOK $602,441,000.00
  • Revenue This Year
  • OCGN N/A
  • COOK $0.06
  • Revenue Next Year
  • OCGN N/A
  • COOK $3.18
  • P/E Ratio
  • OCGN N/A
  • COOK N/A
  • Revenue Growth
  • OCGN N/A
  • COOK 0.80
  • 52 Week Low
  • OCGN $0.52
  • COOK $1.28
  • 52 Week High
  • OCGN $1.67
  • COOK $3.97
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 54.73
  • COOK 47.45
  • Support Level
  • OCGN $0.99
  • COOK $1.88
  • Resistance Level
  • OCGN $1.18
  • COOK $2.05
  • Average True Range (ATR)
  • OCGN 0.08
  • COOK 0.10
  • MACD
  • OCGN 0.00
  • COOK -0.02
  • Stochastic Oscillator
  • OCGN 54.55
  • COOK 1.92

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

Share on Social Networks: